首页> 外文期刊>International journal of oncology >Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review)
【24h】

Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review)

机译:致癌性炎症过程的分子生物学。 I.非致癌和致癌病原体,无病原体的固有炎症反应以及microRNA / DNA相互作用(综述)

获取原文
           

摘要

In some inflammasomes tumor cells are generated. The internal environment of the inflammasome is conducive to the induction of malignant transformation. Epigenetic changes initiate this process. The subverted stromal connective tissue cells act to promote and sustain the process of malignant trans-formation. In its early stages, the premalignant cells depend on paracrine circuitries for the reception of growth factors. The ligands are derived from the connective tissue, and the receptors are expressed on the recipient premalignant cells. The initial events are not a direct attack on the proto-oncogenes, and thus it may be entirely reversible. Epigenetic processes of hypermethylation of the genes at the promoters of tumor suppressor genes (to silence them), and deacetylation of the histones aimed at the promoters of proto-oncogenes (to activate them) are on-going. A large number of short RNA sequences (interfering, micro-, short hairpin, non-coding RNAs) silence tumor suppressor genes, by neutralizing their mRNAs. In a serial sequence oncogenes undergo amplifications, point-mutations, translocations and fusions. In its earliest stage, the process is reversible by demethylation of the silenced suppressor gene promoters (to reactivate them), or re-acetylation of the histones of the oncogene promoters, thus de-activating them. The external administration of histone deacetylase inhibitors usually leads to the restoration of histone acetylation. In time, the uncorrected processes solidify into constitutive and irreversible gene mutations. Some of the pathogens inducing inflammations with consquential malignant transformation contain oncogenic gene sequences (papilloma viruses, Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, hepatitis?B and C viruses, Merkel cell polyoma virus, Helicobacter pylori, enterotoxigenic Bacteroides fragilis). These induced malignancies may be multifocal. Other pathogens are devoid of any known oncogenic genomic sequences (mycoplasma vav-carcinogenesis, chlamydia MALT-lymphoma genesis). In these cases the host's inflammatory reactions induce the malignant transformation in serial sequences of gene alterations initiated by hypoxia and reactive oxygen and nitrogen species generation. Carcinogenic intrinsic inflammatory processes endogenously initiated without a pathogen are recognized. Chronic inflammatory processes signal the RNA/DNA complex. In response, the DNA may revert into its ancient primordial ‘immortal’ format, which the clinics recognize as ‘oncogenesis’. The DNA remains the ultimate master of bioengineering in order to sustain life. A discussion on the most versatile and resistant primordial RNA/DNA complex and the pre-, proto-, and unicellular world in which they co-existed is included.
机译:在一些炎性体中,产生肿瘤细胞。炎性体的内部环境有利于诱导恶性转化。表观遗传的变化引发了这一过程。颠覆的基质结缔组织细胞起促进和维持恶性转化过程的作用。在其早期阶段,恶变前细胞依赖旁分泌回路来接受生长因子。配体源自结缔组织,并且受体在受体恶变前细胞上表达。最初的事件不是对原癌基因的直接攻击,因此可能是完全可逆的。肿瘤抑制基因启动子上的基因超甲基化(使它们沉默)以及针对原癌基因启动子的组蛋白去乙酰化(激活它们)的表观遗传过程正在进行中。大量的短RNA序列(干扰,微发夹,短发夹,非编码RNA)通过中和它们的mRNA而使肿瘤抑制基因沉默。在系列序列中,癌基因经历扩增,点突变,易位和融合。在最早的阶段,该过程可通过沉默抑制基因启动子的去甲基化(以使其重新激活)或癌基因启动子的组蛋白重新乙酰化从而使其失活来逆转。组蛋白脱乙酰基酶抑制剂的外部给药通常导致组蛋白乙酰化的恢复。随着时间的流逝,未纠正的过程会固化为组成型和不可逆的基因突变。伴随恶性转化而诱发炎症的某些病原体包含致癌基因序列(乳头瘤病毒,爱泼斯坦-巴尔病毒,卡波济氏肉瘤相关疱疹病毒,乙型和丙型肝炎病毒,默克尔细胞多瘤病毒,幽门螺杆菌,易产肠毒素的拟杆菌)。这些诱发的恶性肿瘤可能是多灶性的。其他病原体没有任何已知的致癌基因组序列(支原体vav致癌作用,衣原体MALT淋巴瘤发生)。在这些情况下,宿主的炎症反应在由缺氧和活性氧和氮物质生成引发的基因改变的系列序列中诱导恶性转化。认识到无病原体内源性引发的致癌内在炎症过程。慢性炎症过程向RNA / DNA复合体发出信号。作为回应,脱氧核糖核酸可能恢复成其古老的原始“永生”形式,临床上将其称为“致癌作用”。 DNA仍然是维持生命的生物工程学的终极大师。讨论了最通用和最有抵抗力的原始RNA / DNA复合体,以及它们共存的前,原始和单细胞世界。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号